Free Newsletter
Will Pfizer layoffs hit again in January?
Brace yourselves, Pfizer folks. Word is that another round of layoffs is on the way early next year. Industry analysts have been digging through the numbers, and they don't think the company has cut enough jobs. Meanwhile, talk around Pfizer's many water coolers is that the axe will fall--again--in late January.
Two years ago, Pfizer cut 20 percent of its sales and marketing staff; it has chopped 14,000 jobs, total, since January of 2007. And the company is in the middle of a $2 billion restructuring plan. Then, a few months ago, the company reorganized into three business units. Execs said at the time that there would be no layoffs.
But as Jim Edwards at BNet Pharma reports, sales reps are buzzing about another round of cuts. ("It really does feel like this is the Titanic slowly sinking," noted one CafePharma commenter ) And analysts are saying that drugmakers in general need to slash their sales forces by another 25 percent or so, Pfizer included.
- read the post at BNet
Related Articles:
Pfizer R&D staff braces for layoffs
Pfizer dumping heart disease focus in restructuring
Pfizer: $800M in cuts to hit 4Q
Pfizer CFO speaks frankly, carries big ax
Pfizer--Top 5 layoffs of 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: